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BRIEF REPORT
Decreased Intrinsic Brain Connectivity Is Associated With Reduced Clinical Pain
in Fibromyalgia
Vitaly Napadow,1 Jieun Kim,2 Daniel J. Clauw,3 and Richard E. Harris3
Objective. A major impediment to the develop-
ment of novel treatment strategies for fibromyalgia
(FM) is the lack of an objective marker that reflects
spontaneously reported clinical pain in patients with
FM. Studies of resting-state intrinsic brain connectivity
in FM have demonstrated increased insular connectiv-
ity to the default mode network (DMN), a network
whose activity is increased during nontask states. More-
over, increased insular connectivity to the DMN was
associated with increased spontaneous pain levels. How-
ever, as these analyses were cross-sectional in nature,
they provided no insight into dynamic changes in con-
nectivity or their relationship to variations in self-
reported clinical pain. The purpose of this study was to
evaluate longitudinal changes in the intrinsic brain
connectivity of FM patients treated with nonpharmaco-
logic interventions known to modulate pain levels in this
patient population, and to test the hypothesis that the
reduction of DMN–insula connectivity following therapy
would correlate with diminished pain.
Methods. Seventeen FM patients underwent
resting-state functional magnetic resonance imaging at
baseline and following 4 weeks of a nonpharmacologic
intervention to diminish pain. Intrinsic DMN connec-
tivity was evaluated using probabilistic independent
components analysis. Longitudinal changes in intrinsic
DMN connectivity were evaluated by paired analysis,
and correlations between longitudinal changes in clini-
cal pain and changes in intrinsic DMN connectivity
were investigated by multiple linear regression analysis.
Changes in clinical pain were assessed with the short
form of the McGill Pain Questionnaire (SF-MPQ).
Results. Clinical pain as assessed using the sen-
sory scale of the SF-MPQ was reduced following therapy
(P 0.02). Intrinsic DMN connectivity to the insula was
reduced, and this reduction correlated with reductions
in pain (corrected P < 0.05).
Conclusion. Our findings suggest that intrinsic
brain connectivity can be used as a candidate objective
marker that reflects changes in spontaneous chronic
pain within individual FM patients. We propose that
intrinsic connectivity measures could potentially be
used in either research or clinical settings as a comple-
mentary, more objective outcome measure for use in
FM.
Fibromyalgia (FM) is a functional chronic pain
syndrome characterized by diffuse hyperalgesia and
spontaneous widespread pain (1). Multiple studies have
characterized functional, structural, and neurochemical
brain changes in patients with FM (2). Since most of
these studies have been cross-sectional in nature, they
do not address whether the changes in brain structure,
function, and neurochemistry are a cause of the pain, a
consequence, or simply factors associated with chronic
pain. In most of the studies that used functional mag-
netic resonance imaging (fMRI) to assess changes in
response to pain stimuli, information about hyperalgesia
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was provided, but information on ongoing spontaneous
pain was not. Recently, we reported that use of an fMRI
technique that assesses resting or intrinsic brain connec-
tivity provides neurobiologic correlates to self-reported
spontaneous clinical pain in patients with FM (3). Re-
sults of fMRI showed that FM patients displayed greater
connectivity between the insula and the default mode
network (DMN), and the degree of connectivity was
directly associated with the intensity of ongoing sponta-
neous pain. However, that cross-sectional analysis did
not assess whether the connectivity could have potential
as a brain imaging marker that reflects dynamic longi-
tudinal changes in pain in FM patients undergoing
therapy.
For FM and chronic pain in general, effective
analgesic therapies and better understanding of the
pathophysiology underlying chronic pain syndromes are
needed. Indeed, these two factors are likely related: a
better understanding of the mechanistic pathways un-
derlying specific pathology in subgroups of patients
could be used to optimize and enhance therapy for
specific individuals with FM. Subjective self-reports of
pain symptoms most likely lack the specificity needed to
identify phenotypes of specific pathologic factors in
individual patients; however, as FM is increasingly char-
acterized as a disorder in central nervous system func-
tioning (1), a noninvasive neuroimaging marker could
greatly improve our ability to characterize and track pain
symptoms in FM patients in longitudinal trials.
Evaluation of intrinsic brain connectivity by
fMRI is a relatively recent neuroimaging approach.
Intrinsic connectivity assesses spontaneous neural and
metabolic activity that occurs in a resting basal state
since imaging is performed while subjects rest quietly in
the scanner. We and others have proposed that this
resting connectivity is related to the spontaneous
chronic pain experienced by patients with FM (3). It may
reflect synaptic neurotransmission as interregional cor-
relations in the fMRI signal follow known structural
monosynaptic and polysynaptic pathways (4). Thus, con-
nectivity likely reflects neurophysiologically meaningful
activity, and occurs within distinct networks of the brain.
One such constellation is the DMN, an aggregate of the
brain structures that have been associated with self-
referential cognition and autobiographical memory (5).
In addition to FM (3), altered intrinsic DMN connectiv-
ity has been detected in other chronic pain conditions
(6). We found that the DMN demonstrated greater
connectivity to the insula in FM patients compared to
healthy adults, and, perhaps even more importantly,
increasing DMN–insula connectivity was associated with
increasing levels of spontaneous pain (3). These results
suggested that intrinsic connectivity could serve as a
brain biomarker for chronic pain, a hypothesis that
would be bolstered if longitudinal changes in intrinsic
DMN connectivity were associated with changes in the
clinical pain state.
Our current study was designed to evaluate lon-
gitudinal changes in intrinsic brain connectivity in FM
patients treated with a nonpharmacologic intervention
that is known to modulate pain levels in this patient
population (7). Subjects underwent scanning before and
after therapy and were evaluated for intrinsic connectiv-
ity. We hypothesized that DMN–insula connectivity
would be reduced following therapy and would correlate
with diminished pain.
PATIENTS AND METHODS
Patients. As part of an ongoing study investigating
nonpharmacologic treatment in FM, 17 female patients
(mean  SD age 46.4  15.5 years) underwent MRI during 2
scanning sessions spaced a mean  SD of 29.8  4.0 days
apart. Scanning sessions occurred before (mean  SD 4.0 
2.4 days) and after (4.4  3.8 days) 9 treatments of either
acupuncture or sham acupuncture using a protocol that has
been shown to decrease pain levels in FM patients (7,8). The
treatment assignment was not considered during analyses, as
we were not interested in any differences between treatment
with acupuncture and sham acupuncture, but rather how
changes in intrinsic brain connectivity are related to changes in
pain. All subjects provided written informed consent, and
protocols were approved by the University of Michigan Insti-
tutional Review Board.
Participant inclusion and exclusion criteria have been
reported previously (3). Briefly, patients had FM that had met
the 1990 American College of Rheumatology criteria for the
diagnosis of FM (9) for at least 1 year, had continued presence
of pain on 50% of days, and were willing to maintain their
existing therapy and limit the introduction of any new medi-
cations or treatment modalities for control of FM symptoms
during the study.
Spontaneous clinical pain. Prior to scanning, subjects
were asked to rate the intensity of their FM pain using the
short form of the McGill Pain Questionnaire (SF-MPQ) (10).
The sensory and affective subscales were contrasted between
baseline and posttherapy time points by Student’s t-test (sig-
nificant at   0.05).
Intrinsic connectivity fMRI data acquisition. Six min-
utes of resting-state fMRI data were collected as the first
functional scan run in the session. We used a spiral in-out
gradient echo T2*-weighted blood oxygenation level–
dependent pulse sequence (repetition time [TR]/echo time
[TE] 2,000/30 msec, 180 volumes, 43 slices parallel to the plane
containing the anterior and posterior commissures, voxel size
3.13  3.13  4.0 mm) running on a 3T Signa Excite scanner
(GE) equipped with an 8-channel head coil. Patients were
instructed to close their eyes and to rest comfortably during the
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functional scan without moving or falling asleep. Structural
data were also collected using a spoiled gradient pulse se-
quence (TR/TE/inversion time 14/5.5/300 msec, flip angle 20°,
124 contiguous axial slices, voxel size 1.0  1.0  1.5 mm).
Physiologic data and fMRI data were collected simul-
taneously, as cardiorespiratory fluctuations are known to in-
fluence fMRI intrinsic connectivity estimation within several
brain networks. Cardiac data were acquired using an infrared
pulse oximeter (GE) attached to the right middle finger.
Respiratory volume data were acquired using an MR-
compatible belt (GE) placed around the subject’s rib cage.
Intrinsic connectivity fMRI data analysis. Data analy-
sis was performed using FSL (www.fmrib.ox.ac.uk/fsl). Data
were corrected for motion artifact (MCFLIRT) and for car-
diorespiratory artifacts using the RETROICOR algorithm.
FSL BET was used to perform brain extraction on functional
data (i.e., to remove non-brain tissue from the image). Data
were smoothed using a full width half maximum Gaussian
kernel of 6 mm and a temporal high-pass filter (f  0.008 Hz).
Resting-state fMRI data on individual patients were
analyzed using the previously validated dual-regression inde-
pendent components analysis (ICA) through MELODIC. Im-
portantly, this approach has been reported to have moderate-
to-high test–retest reliability both short term (within the
scanning session) and long term (several weeks after the
scanning session) in healthy adults (11). We used the same
approach in our previous cross-sectional study investigating
the relationship between pain and intrinsic brain connectivity
in FM patients (3). Dual-regression ICA allows for voxelwise
comparisons of resting-state functional connectivity by first
temporally concatenating resting fMRI data from all subjects,
followed by back-reconstructing the group intrinsic connectiv-
ity networks (ICNs) for individual subjects, which are then
used for within- and between-subject group and difference
maps. We limited the number of independent components to
25 and used our previous goodness-of-fit tests (3,12) to identify
different ICNs. Our analysis was focused on the DMN net-
work, as resting connectivity within this network was found to
be altered in FM patients compared to healthy adults (3), while
acupuncture has been shown to modulate resting-state DMN
connectivity (12). As in our previous analyses, the generalized
linear model included multiple temporal regressors of no
interest, including time series from white matter and ventric-
ular regions, and cardiac and respiratory variability defined by
convolving the heart rate time series and respiratory variations
with appropriate cardiac and respiratory transfer functions.
This was done to limit any residual shared variance with
non-neuronal (e.g., cardiorespiratory physiologic) processes.
No global signal regression was used.
Mixed-effects group analyses were used to contrast
intrinsic DMN connectivity at baseline and posttherapy. To
more closely link changes in resting DMN connectivity with
analgesic response, multiple linear regression analysis was
performed using the change in DMN connectivity and the
change in spontaneous pain rating (sensory/affective subscores
of the SF-MPQ). This pain score was adjusted for age by
including this variable in the model, as age is known to
influence ICN connectivity. Results were determined to be
significant using cluster correction for multiple comparisons
(corrected P values less than or equal to 0.05 considered
significant).
Figure 1. Levels of pain in fibromyalgia patients before therapy (solid
bars) and after therapy (open bars) as assessed with the short form of
the McGill Pain Questionnaire. Clinical pain levels were assessed just
prior to functional magnetic resonance imaging. There was a signifi-
cant reduction in pain on the McGill sensory subscale and a trend
toward diminished pain on the McGill affective subscale following
therapy. Bars show the mean  SEM.   P  0.02;   P  0.09.
Figure 2. Default mode network (DMN) connectivity to the anterior
insula in fibromyalgia patients before and after therapy. DMN con-
nectivity was positive at baseline, and was significantly reduced follow-
ing therapy. Bars show the mean  SEM. R Ant Insula  right
anterior insula. Color figure can be viewed in the online issue, which
is available at http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)
1529-0131.
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RESULTS
Resting-state fMRI data were collected from all
17 female subjects, before and after therapy (mean 
SD 29.8  4.0 days between scans). All subjects toler-
ated the intervention and there were no dropouts.
After therapy, there was significant diminishment
of clinical pain as assessed according to the SF-MPQ
sensory subscore (mean  SEM 6.06  0.85, versus
10.71  1.93 at baseline; P  0.02). Additionally, there
was a trend toward diminished pain as assessed accord-
ing to the SF-MPQ affective subscore (1.35  0.31,
versus 2.24  0.47 at baseline; P  0.09) (Figure 1).
Following therapy, reduced intrinsic brain con-
nectivity between the DMN and the right anterior/
middle insula was detected (z  3.63; Montreal Neu-
rological Institute [MNI] coordinates x, y, z  39 mm, 7
mm, 5 mm, respectively) (Figure 2). Reduced connec-
tivity between the DMN and right putamen was also
noted posttreatment (z  3.57; MNI coordinates x, y,
z  26 mm, 1 mm, 1 mm, respectively). Interestingly,
diminished self-reported spontaneous clinical pain cor-
related positively with reduced connectivity between the
DMN and left anterior insula (z  3.21; MNI coordi-
nates x, y, z  38 mm, 12 mm, 18 mm, respectively)
(Figure 3), as well as the left amygdala (z  3.22; MNI
coordinates x, y, z  24 mm, 1 mm, 21 mm,
respectively). A subthreshold cluster, which survived at
an uncorrected P value of less than 0.005 (minimum
cluster size 400 mm2), was also found in the right
posterior insula (z  3.74; MNI coordinates x, y, z  32
mm, 24 mm, 16 mm, respectively).
DISCUSSION
Our previous studies linked increased intrinsic
DMN–-insula connectivity to spontaneous pain in FM
patients (3). The current study demonstrates that DMN–
insula connectivity is decreased following successful
Figure 3. Relationship between changes in age-adjusted clinical pain and intrinsic default mode network (DMN) in patients with fibromyalgia.
Multiple linear regression analysis demonstrated that the change in age-adjusted clinical pain at the time of functional magnetic resonance imaging
correlated with reduced intrinsic DMN connectivity to the left anterior insula (L aIns). A subthreshold cluster was also found in the right posterior
insula (R pIns).
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longitudinal therapy. Furthermore, diminished pain cor-
related positively with reduced intrinsic connectivity
between the DMN and anterior insula. These results
provide preliminary support for the use of intrinsic brain
connectivity as a candidate objective marker for the
subjective experience of clinical pain in FM. Moreover,
we have demonstrated the utility of using intrinsic
connectivity as a surrogate objective outcome measure
for interventional trials in FM, especially in early proof-
of-concept trials.
Previous studies have demonstrated insular in-
volvement in the multidimensional (sensory, affective,
cognitive) pain state. The insula is one of the most
commonly activated brain regions in neuroimaging stud-
ies of acute experimental pain (13). However, the insula
does not just process pain signals, and has been associ-
ated with multiple aversive or otherwise salient experi-
ential states, both interoceptive (14) and exteroceptive
(15). As DMN processing has been attributed to self-
referential cognitive processing, we could speculate that
increased DMN–insula connectivity in FM may reflect a
state of hyperawareness to pain, which has been incor-
porated into the patient’s sense of self. Longitudinal
reduction in DMN–insula connectivity may then follow,
accompany, or even play a causal role in the reduction of
pain experienced during analgesic intervention. At this
time we cannot differentiate between these hypotheses.
The use of an insula-associated neuroimaging
marker to track FM pain has been explored in previous
studies. For instance, we have shown that insular gluta-
mate levels as assessed with proton magnetic resonance
spectroscopy were elevated in FM patients and were
found to correlate positively with changes in clinical pain
(8,16). The current study adds to our understanding of
insular involvement in clinical pain reported by patients
and shows again that longitudinal changes in pain in FM
are related to longitudinal changes in insular physiology.
We used acupuncture as the nonpharmacologic
therapy in this study. This intervention was used instead
of pharmacologic intervention as there is less risk of
modulating neurovascular coupling, and acupuncture
(both real and sham) is known to reduce pain levels in
FM patients (7). Our previous studies have also demon-
strated that acupuncture increases intrinsic DMN con-
nectivity to pain-modulatory and affective brain areas
such as the anterior cingulate cortex, periaqueductal
gray matter, and amygdala (12). The effect was short
term (immediately following acupuncture stimulation),
whereas our present study showed that more sustained
therapy reduced DMN connectivity to the insula. It is
not currently known whether the longitudinal changes
found over multiple weeks in this trial are related to the
more immediate stimulus-related change we observed
previously. Future studies are needed to clarify this.
In conclusion, our findings suggest that intrinsic
brain connectivity can be used as a candidate objective
marker that is sensitive enough to track pain levels in
FM. Intrinsic connectivity can be used as a complemen-
tary, objective outcome measure in longitudinal clinical
trials of different therapies in this patient population.
Incorporation of this marker in future clinical trials may
provide a better understanding of the mechanistic path-
ways underlying various interventions.
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Clinical Image: The Harlequin sign—benign blush or the bearer of bad news?
The patient, a 41-year-old woman, presented to the rheumatology clinic. She reported that, for the past 3 years, she experienced
unilateral facial flushing and coldness of the ipsilateral hand after vigorous exercise. Results of the neurologic assessment, including
tests for autonomic function, were normal. Findings of magnetic resonance imaging of the patient’s brain, neck, thoracic outlet, and
chest were also normal. The patient mentioned that her son experienced similar symptoms, although he had not been formally
assessed. A diagnosis of Harlequin syndrome was made in light of the patient’s characteristic symptoms, which included unilateral
flushing and hyperhidrosis after exercise (Wasner G, Maag R, Ludwig J, Binder A, Schattschneider J, Stingele R, et al. Harlequin
syndrome—one face of many etiologies. Nat Clin Pract Neurol 2005;1:54–9). Harlequin syndrome results from disruption of
sympathetic fibers at or distal to the sympathetic ganglia at T2–T3, with proximally located lesions associated with greater autonomic
dysfunction. To date, 91 patients with Harlequin syndrome have been reported, and in 64% of these no cause was identified. In the
remaining patients, mediastinal tumors, paravertebral thoracic blocks, and neck-mass resection accounted for the majority of the
cases. In some cases of Harlequin syndrome there may be a generalized disorder of the autonomic nervous system constituting part
of a spectrum of conditions involving generalized dysautonomia, such as Ross syndrome and Adie syndrome. Coldness of the
ipsilateral arm, suggestive of multifocal involvement, was mentioned in only 1 other case report (Moon SY, Shin DI, Park SH,
Kim JS. Harlequin syndrome with crossed sympathetic deficit of the face and arm. J Korean Med Sci 2005;20:329–30). Hereditary
Harlequin syndrome has not yet been described. Management involves ruling out structural lesions in the paravertebral region, after
which education, reassurance, and procedures to improve cosmesis form the mainstay of therapy.
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